Casirivimab,Imdevimab
sanofi
['imab ']
 abs 2195 fagni, et al casirivimab and imdevimab for prep n=26 imid, inadequate response to 3 doses serum, saliva tested for abs at d1, d3 prep led to stable ab levels dates not given but i guess pre omicron? #acr22
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010